Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Kiwamoto, T.
  • Kawasaki, N.
  • Paulson, James
  • Bochner, B. S.

publication date

  • September 2012

journal

  • Pharmacology & Therapeutics  Journal

subject areas

  • Animals
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation, B-Lymphocyte
  • Antigens, Differentiation, Myelomonocytic
  • Eosinophilia
  • Eosinophils
  • Humans
  • Lectins
  • Mast Cells
  • Mastocytosis
  • Molecular Targeted Therapy
  • Nanoparticles
  • Polysaccharides
scroll to property group menus

Research

keywords

  • Allergic diseases
  • Apoptosis
  • Glycan ligands
  • Liposomes
  • Siglec-8
  • Siglec-F
scroll to property group menus

Identity

PubMed Central ID

  • PMC3587973

International Standard Serial Number (ISSN)

  • 0163-7258

Digital Object Identifier (DOI)

  • 10.1016/j.pharmthera.2012.06.005

PubMed ID

  • 22749793
scroll to property group menus

Additional Document Info

start page

  • 327

end page

  • 336

volume

  • 135

issue

  • 3

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support